oxazoles has been researched along with Coronary Heart Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buse, JB; Grobbee, DE; Henry, RR; Lincoff, AM; Malmberg, K; Mellbin, L; Neal, B; Nicholls, SJ; Nozza, A; Rydén, L; Schrieks, IC; Schwartz, GG; Stähli, BE; Svensson, A; Tardif, JC; Wedel, H; Weichert, A | 1 |
| Bengus, M; Califf, R; Ditmarsch, M; Erdmann, E; Gerstein, HC; Malmberg, K; Ruilope, L; Schwartz, GG; Svensson, A; Volz, D; Wedel, H | 1 |
| Poole-Wilson, PA | 1 |
| Belli, R; Biasci, R; Bruna, C; Caruzzo, C; Gaschino, G | 1 |
| Buster, DC; Castro, MM; Geraldes, CF; Jeffrey, FM; Malloy, CR; Sherry, AD | 1 |
| Bencze, WL; DeStevens, G; Hess, R | 1 |
1 review(s) available for oxazoles and Coronary Heart Disease
| Article | Year |
|---|---|
Hypolipidemic agents.
Topics: Acetates; Adult; Animals; Azoles; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet; Dogs; Esters; Estrogens; Female; Haplorhini; Heart Diseases; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Mevalonic Acid; Mice; Middle Aged; Nicotinic Acids; Oxazoles; Prostaglandins; Pyrazoles; Pyridines; Rats; Steroids; Thyroxine | 1969 |
3 trial(s) available for oxazoles and Coronary Heart Disease
| Article | Year |
|---|---|
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Adiponectin; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxazoles; Retrospective Studies; Stroke; Thiophenes; Treatment Outcome | 2018 |
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Early Termination of Clinical Trials; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Myalgia; Myocardial Infarction; Myositis; Oxazoles; Peripheral Arterial Disease; PPAR alpha; PPAR gamma; Prediabetic State; Stroke; Thiophenes; Treatment Outcome | 2015 |
[Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
Topics: Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Oxazoles; Platelet Adhesiveness; Platelet Aggregation | 1979 |
2 other study(ies) available for oxazoles and Coronary Heart Disease
| Article | Year |
|---|---|
DMO method for intracellular pH.
Topics: Animals; Cell Membrane Permeability; Coronary Disease; Hydrogen-Ion Concentration; Myocardium; Oxazoles | 1976 |
Influence of global ischemia on intracellular sodium in the perfused rat heart.
Topics: Animals; Coronary Disease; Heart; Magnetic Resonance Spectroscopy; Male; Myocardium; Oxazoles; Perfusion; Pyrimidinones; Rats; Rats, Inbred Strains; Sodium; Spectrophotometry, Atomic; Thulium | 1990 |